FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 62 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,309,000 | +9.5% | 11,203,881 | 0.0% | 0.74% | -19.3% |
| Q3 2019 | $34,060,000 | +207.0% | 11,203,881 | +140.3% | 0.92% | +260.0% |
| Q2 2019 | $11,095,000 | -36.5% | 4,661,824 | 0.0% | 0.26% | -48.3% |
| Q1 2019 | $17,482,000 | +10.3% | 4,661,824 | 0.0% | 0.49% | -18.2% |
| Q4 2018 | $15,850,000 | -11.0% | 4,661,824 | +50.0% | 0.60% | +26.7% |
| Q3 2018 | $17,806,000 | +218.1% | 3,107,424 | +178.1% | 0.48% | +223.8% |
| Q2 2018 | $5,598,000 | -2.3% | 1,117,324 | 0.0% | 0.15% | -8.7% |
| Q1 2018 | $5,732,000 | -14.6% | 1,117,324 | 0.0% | 0.16% | -27.8% |
| Q4 2017 | $6,715,000 | -45.9% | 1,117,324 | -50.0% | 0.22% | -5.9% |
| Q3 2017 | $12,402,000 | +139.2% | 2,234,648 | +100.0% | 0.24% | -9.2% |
| Q2 2017 | $5,184,000 | -20.8% | 1,117,324 | -15.5% | 0.26% | -30.0% |
| Q1 2017 | $6,549,000 | -55.4% | 1,322,994 | 0.0% | 0.37% | -64.3% |
| Q4 2016 | $14,685,000 | +15.5% | 1,322,994 | -3.7% | 1.04% | +27.2% |
| Q3 2016 | $12,717,000 | +151.9% | 1,373,284 | +72.7% | 0.82% | +134.6% |
| Q2 2016 | $5,048,000 | – | 795,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|